Prostate Cancer - Results from #22000

Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials - Abstract October 23, 2013

Is there a relation between the radiation dose to the different sub-segments of the lower urinary tract and urinary morbidity after brachytherapy of the prostate with I-125 seeds? - Abstract October 23, 2013

Prostate-specific antigen velocity risk count predicts biopsy reclassification for men with very-low-risk prostate cancer - Abstract October 23, 2013

Prostate cancer disease characteristics for foreign-born South Asian men living in the United States - Abstract October 23, 2013

Transperineal biopsy of the prostate - Is this the future? - Abstract October 23, 2013

Diagnostic dilemma in histopathology report following robot assisted laparoscopic prostatectomy: Tumour 'hide and seek' - Abstract October 23, 2013

UroToday® introduces Urology TUBE™ to provide state-of-the-art delivery of rich media content to its global readership October 22, 2013

Bladder outlet obstruction in men with castration-resistant prostate cancer - Abstract October 21, 2013

PSA doubling time as a progression criterion in an active surveillance programme for patients with localised prostate cancer - Abstract October 21, 2013

Probiotics for rectal volume variation during radiation therapy for prostate cancer - Abstract October 21, 2013

Differing leukocyte gene expression profiles associated with fatigue in patients with prostate cancer versus chronic fatigue syndrome - Abstract October 21, 2013

Predicting risk of prostate cancer in men receiving finasteride: Effect of prostate volume, number of biopsy cores, and American Urological Association Symptom Score - Abstract October 21, 2013

Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy - Abstract October 21, 2013

Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy? - Abstract October 21, 2013

The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level-Can it rule out clinically significant prostate cancer? - Abstract October 21, 2013

The costs of identifying undiagnosed prostate cancer in asymptomatic men in New Zealand general practice - Abstract October 21, 2013

May non-metastatic clinically localized castration-resistant prostate cancer after primary androgen ablation benefit from salvage prostate radiotherapy? - Abstract October 21, 2013

Percentage of high-grade tumor volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared to Gleason score - Abstract October 19, 2013

Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer - Abstract October 19, 2013

A positive real-time elastography is an independent marker for detection of high-risk prostate cancers in the primary biopsy setting - Abstract October 19, 2013

Page 1101 of 1435